Call for Enterprises, Start-Ups and Projects

Assobiotec (the Italian Association for the development of biotechnology), Intesa Sanpaolo and Innovhub SSI (Milan Chamber of Commerce Special Agency) are delighted to invite companies and researchers in the biotech and nanobiotech field to participate in the seventh edition of BioInItaly Investment Forum 2014 & Intesa Sanpaolo Start-Up Initiative. 

1. Initiative Overview 
BioInItaly Investment Forum & Intesa Sanpaolo Start-Up Initiative is a yearly investment forum open to established biotech and nanobiotech companies, start-ups and projects from Italy but also from other European countries seeking for financial resources. In a unique end-to-end program, the applicants will benefit from coaching, networking and direct contact with international investors through a series of focused events. The initiative is aimed to provide the applicants with the competences, connections and access to potential Investors they need to go to market and scale. 
2. Competition Structure 
BioInItaly Investment Forum & Intesa Sanpaolo Start-Up Initiative is designed as a yearlong, three-phase investment arena: 
 • Phase 1 – Launch. Participants are invited to submit their ideas and proposals using the specific form downloadable from the web site of Assobiotec ( and Innovhub SSI ( At the end of Phase 1, a maximum of 20 applicants are shortlisted for participating to Phase 2. 
• Phase 2 – Boot Camp and Investment Forum. The selected participants will attend a two-day boot camp session in Milan. The session will allow participants to benefit from extensive training to refine their business plans and craft presentations aimed specifically at the investor arena. This unique program will be run in cooperation with Silicon Valley angel investor network Maverick Angels. At the end of Phase 2 a session of deal line-up will take place in front of a group of investors and the selected finalists will be allowed to move forward in the Investment Forum which will be held in Milan on April 2nd and 3rd 2014. 
• Phase 3 – International Roadshow. Following the Investment Forum, some selected participants will be invited to take part in a series of Arena Meetings to be held in London, Frankfurt, Paris, during the course of 2014/2015. These unique networking events will provide contestants with the opportunity to pitch to an audience of top investors and receive detailed feedback following each meeting. 
3. Eligibility 
Applicants wishing to take part in this initiative must meet the following requirements: 
• Contestants must have a company / project that fits within one of the following biotech and nanobiotech categories: health, agriculture, environment, industry, food, bioinformatics, energy  
• Contestants must indicate their financial need 
Participants of the previous edition will be considered only in presence of a new business plan. 
4. Submission Method 
The competition involves three phases. 
Phase 1. Applicants will complete the submission form (see Phase 1 above) and submit it to:, with Reference “BioInItaly 2014 Investment Forum”. 
The deadline for submissions is set as midnight (GMT+1) on Friday February 14, 2014
Phase 2. Please note the following key dates for Phase 2: 
➢ March 17-18: boot camp session. Selected participants will take part in training sessions 
➢ March 18 -30: one to one sessions. Selected participants will receive personalized mentoring 
➢ March 31-April 1: deal line-up. Selected participants will pitch to a group of selected investors and industry experts, who will select about 10 finalist companies to be admitted to the Investor Arena Meeting 
Phase 3. Following the deal line-up, selected finalists will take part in the Investment Forum, that will be held on April 2-3, 2014 in Milan (Palazzo Besana, Piazza Belgioioso 1). 
Dates for subsequent international meetings to be defined. 
5. Selection Criteria 
The proposals submitted by contestants will be judged by a Selection Panel according to the following criteria: 
1) Strength of Product / Technology. What are the strengths of the product and its technical standards? Is there a need for the proposed technology and does it offer an effective solution to a problem in the field? Is the product/technology original and disruptive? 
2) Business Model. Is the business model clear and sustainable? What is its capacity to monetize and what is the estimated time to market? 
3) Market Size and Scalability. What are the size and attractiveness of the target market? Can the proposed technology or solution be deployed at a scale? 
4) Barriers to Entry and Competitive Advantage. Is there a clear and sustainable competitive advantage in the proposed solution and are the barriers to entry strong enough to prevent competitors from penetrating the market? 
5) Team. What is the composition of the team? Is there a balance in terms of knowledge and expertise? What are their strengths and weaknesses? How strong is their overall commitment to the business? 
6) Financials. Is the team’s business plan robust? What is their strategy for growing and financing the company in the medium term (3-5 years)? 
 At least 50% of the applicants will be selected considering as necessary condition their operative site in Italy or the intention to open it in Italy. 
The Selection Panel will be composed by experienced and qualified professionals from the biotech and finance world. 
The presentation that will be considered the most effective – according the rating assessment of the BioInItaly Commission and the Selection Panel – will be awarded the Corbelli Prize*, consisting in the coverage by Assobiotec and Innovhub SSI of travel and accomodation expenses for one edition of the European road show (Frankfurt, London or Paris). 
6. Confidentiality 
• The staff of the three organizing entities (Assobiotec, Intesa Sanpaolo and Innovhub SSI) as well the members of the Selection Panel will have access to entry materials. 
• Entering teams must recognize that any information submitted through entries is at risk of ‘public disclosure’. 
• The organizers, judges and other affiliates of the event will NOT enter into non-disclosure agreements with applicants. 
For information: – 
In memory of Gabriele Corbelli 
Gabriele Corbelli was one of the co-founders of WISE, a nano-biotech start-up who developed an elastic metallized polymer for use in stretchable 
neuromodulation leads (with applications in the diagnosis and treatment of neurodegenerative diseases like Alzheimer's). 
Gabriele, together with his friend and co-founder Luca Ravagnan, was scheduled to pitch at the BioInItaly Investment Forum Intesa Sanpaolo Start-Up Initiative scheduled for April 18, 2012. Only, that is not what happened: during the night before the event, Gabriele passed away in his sleep. 
He was only 31 years old, and driven by a strong passion for innovation and technology which, he dreamed, could help improve the lives of 
neurodegenerative disease patients worldwide. 
In his memory, Assobiotec and Innovhub SSI decided, starting 2013, to dedicate the award for the best biotechnology startup to his name.